Found: 77
Select item for more details and to access through your institution.
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 7, p. 1079, doi. 10.1007/s00432-010-0973-x
- By:
- Publication type:
- Article
Intravascular large B-cell lymphoma presenting with mass lesions in the central nervous system: A report of five cases.
- Published in:
- Pathology International, 2004, v. 54, n. 4, p. 231, doi. 10.1111/j.1440-1827.2004.01613.x
- By:
- Publication type:
- Article
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 6, p. 585, doi. 10.1007/s12185-015-1780-6
- By:
- Publication type:
- Article
The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2014, v. 100, n. 4, p. 379, doi. 10.1007/s12185-014-1649-0
- By:
- Publication type:
- Article
Erratum to: An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen.
- Published in:
- 2011
- By:
- Publication type:
- journal article
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Successful post-remission therapy with a combination of all-trans retinoic acid and arsenic trioxide in an elderly Japanese patient newly diagnosed with acute promyelocytic leukemia.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Analysis of 20-year follow-up study of LVP regimen for adult acute lymphoblastic leukemia.
- Published in:
- 2001
- By:
- Publication type:
- journal article
A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma.
- Published in:
- International Journal of Clinical Pharmacy, 2022, v. 44, n. 2, p. 366, doi. 10.1007/s11096-021-01348-6
- By:
- Publication type:
- Article
Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.
- Published in:
- Internal Medicine, 2023, v. 62, n. 22, p. 3299, doi. 10.2169/internalmedicine.1611-23
- By:
- Publication type:
- Article
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 6, p. 802, doi. 10.1111/bjh.18582
- By:
- Publication type:
- Article
Copper deficiency anaemia.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 161, doi. 10.1111/bjh.12577
- By:
- Publication type:
- Article
Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 6, p. 584, doi. 10.1007/s10147-011-0328-x
- By:
- Publication type:
- Article
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 806, doi. 10.1002/ajh.27237
- By:
- Publication type:
- Article
Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E55, doi. 10.1002/ajh.27176
- By:
- Publication type:
- Article
Mycotic pseudoaneurysm of a pulmonary artery branch caused by Cladosporium.
- Published in:
- Pathology International, 2018, v. 68, n. 1, p. 47, doi. 10.1111/pin.12615
- By:
- Publication type:
- Article
Induced Differentiation of Human Myeloid Leukemia Cells into M2 Macrophages by Combined Treatment with Retinoic Acid and 1α,25-Dihydroxyvitamin D<sub>3</sub>.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113722
- By:
- Publication type:
- Article
Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 12, p. 3311, doi. 10.1007/s00277-023-05425-w
- By:
- Publication type:
- Article
Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2081, doi. 10.1007/s00277-018-3412-8
- By:
- Publication type:
- Article
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 6, p. 957, doi. 10.1007/s00277-014-2013-4
- By:
- Publication type:
- Article
Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-022-00272-9
- By:
- Publication type:
- Article
Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-023-00284-z
- By:
- Publication type:
- Article
Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-022-00272-9
- By:
- Publication type:
- Article
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
- By:
- Publication type:
- Article
The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8931, doi. 10.1002/cam4.3516
- By:
- Publication type:
- Article
Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 11, p. 3223, doi. 10.1002/cam4.925
- By:
- Publication type:
- Article
Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 2, p. 96, doi. 10.1159/000521113
- By:
- Publication type:
- Article
Efficacy of Oral Cytarabine Ocfosfate and Etoposide in the Treatment of Elderly Patients with Higher-Risk Myelodysplastic Syndromes Compared to That in Elderly Acute Myeloid Leukemia Patients.
- Published in:
- Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 152, doi. 10.1159/000351114
- By:
- Publication type:
- Article
Thrombopoietin Levels During Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 9, p. 813, doi. 10.1007/s40261-018-0670-0
- By:
- Publication type:
- Article
Aggressive CD4-CD8-CD45RA<sup>+</sup>CCR10<sup>-</sup> Primary Cutaneous Peripheral T-cell Lymphoma, Not Otherwise Specified: A Case Report.
- Published in:
- Acta Dermato-Venereologica, 2019, v. 99, n. 12, p. 1176, doi. 10.2340/00015555-3310
- By:
- Publication type:
- Article
A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
- Published in:
- Molecular Genetics & Genomic Medicine, 2019, v. 7, n. 4, p. N.PAG, doi. 10.1002/mgg3.591
- By:
- Publication type:
- Article
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
- Published in:
- Case Reports in Oncology, 2023, v. 16, n. 1, p. 353, doi. 10.1159/000530265
- By:
- Publication type:
- Article
Efficacy of Molecular Response at 1 or 3 Months after the Initiation of Dasatinib Treatment Can Predict an Improved Response to Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Japanese Patients with Chronic Myelogenous Leukemia during the Chronic Phase.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2014, v. 54, n. 3, p. 197, doi. 10.3960/jslrt.54.197
- By:
- Publication type:
- Article
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 394, doi. 10.1007/s12185-024-03836-7
- By:
- Publication type:
- Article
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 60, doi. 10.1007/s12185-024-03758-4
- By:
- Publication type:
- Article
Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 2, p. 210, doi. 10.1007/s12185-023-03606-x
- By:
- Publication type:
- Article
Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 5, p. 694, doi. 10.1007/s12185-023-03549-3
- By:
- Publication type:
- Article
Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 395, doi. 10.1007/s12185-020-03032-3
- By:
- Publication type:
- Article
JSH practical guidelines for hematological malignancies, 2018: I. leukemia—3. acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 4, p. 439, doi. 10.1007/s12185-020-02965-z
- By:
- Publication type:
- Article
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer.
- Published in:
- Genes, Chromosomes & Cancer, 1997, v. 19, n. 1, p. 1, doi. 10.1002/(SICI)1098-2264(199705)19:1<1::AID-GCC1>3.0.CO;2-3
- By:
- Publication type:
- Article